Snake venom

Snake venom is a highly modified saliva that contains many different powerful toxins. There are more than 2000 species of snakes living at the present time, and at least 10 % of these produce venom. (see discussion page). Unlike most other predators, snakes swallow prey whole, and, therefore, are especially vulnerable to injury if their prey animals are active. Most snake venoms contain specific proteins that act to (1) paralyze the prey so that it no longer moves (2) interfere with normal blood clotting mechanisms so that the animal goes into shock and (3) begin the digestive process by breaking down the tissues of the prey animal. Venom also acts to deter predators from harming the snake and is an important defense mechanism for those who possess it.

The process of introducing venom into a victim is called "envenoming". Envenoming by snakes is most often done through the wound of their bite, but some species of snake, like the 'spitting cobra', use additional methods, like squirting venom onto the mucous membranes of prey animals (e.g. eyes, nose, and mouth).

Venoms differ from snake species to snake species, and appear to be specialized to dispatch the particular kinds of animals that make up that snake's preferred diet. The great majority of the many biological toxins in snake venom are proteins, generally either with enzymatic activity, or the ability to blockade nerve or muscle cell receptors. With advances in molecular biology over the last few decades, a general schema for the expression of such proteins by genes in the specialized salivary gland that secretes venom is apparent. There is evidence that the exact components of the venom may even change over the course of a snakes lifespan, in species(for example, certain rattlesnakes of the genus Crotalus) who rely on one set of prey animals as juveniles (cold-blooded lizards and other small exotherms) , and a different set of prey animals as adults (warm-blooded rodents).(Ontogenetic Variation in Venom Composition and Diet of Crotalus oreganus concolor: A Case of Venom Paedomorphosis? Stephen P. Mackessy, Kwame Williams, Kyle G. Ashton Copeia Volume 2003, Issue 4 (December 2003) pp. 769–782 DOI: 10.1643/HA03-037.1)

The danger to a human presented by any particular species of venomous snake depends on many factors. First, there is the toxicity of that species venom, which can vary from mildly harmful to highly lethal. Secondly, there is the actual dose of venom the snake is capable of effectively delivering. Finally, there is the liklihood that the snake will attack a person if confronted, rather than withdraw.

Toxicity: LD50

Toxicity of venoms is usually expressed by the LD50: the lowest dose that kills 50% of a group of experimental animals (most often rodents). That dose varies not just between the venoms tested, but also depends on which species of prey animals chosen to receive the venom. Generally, the most toxic venom is the one with the lowest LD50. However, some snakes have venoms that are quite specialized for certain types of prey animals. The venom of the eastern copperhead (I have to look up scientific name) is more lethal to fish and amphibians than to mammals (I have to check reference to make sure I have right species. will be coming). Human susceptibility to a snake venom is generally estimated from the LD50 for rodents. The next factor in assessing the danger of a particular species of venomous snakes' bite is the dose of venom that is actually introduced into the tissues with a bite. As will be discussed, some types of snakes have an extremely efficient mechanism of injecting venom, others have markedly less success in doing so. The amount of venom produced by venomous snakes that is available for secretion with a bite also varies between kinds of snakes, and between individuals (usually by size) of any one species.

Venom characteristics and delivery of venom according to snake family

The venomous snakes are represented in only five families. These are the Colubridae (colubrids), Elapidae (elapids), Hydrophiidae (sea-snakes), Viperidae (true vipers), and Crotalidae (pit vipers). There are variations in the methods of envenomation according to family.

Colubridae (colubrids)

This family of snakes is largest and contains about 2/3 of all living species. These rear-fanged snakes deliver venom under low pressure as compared to the vipers (who inject venom under higher pressure) and chemical studies of venom have been hindered by the difficulty of collecting it in pure condition and in sufficient quantities from live snakes in this family. As more recent collection methods have been devised that overcome some of these problems, scientists have discovered that earlier assumptions about the venom contents were sometimes mistaken. For example, Phospholipase A2 (PLA2),which had been thought to be lacking in venoms in this family has been detected in at least two species.

"Some venoms show high toxicity toward mice, and others are toxic to birds and/or frogs only. Because many colubrids feed on non-mammalian prey, lethal toxicity toward mice is likely only relevant as a measure of potential risk posed to humans. At least five species (Dispholidus typus, Thelotornis capensis, Rhabdophis tigrinus, Philodryas olfersii and Tachymenis peruviana) have caused human fatalities"( BIOCHEMISTRY AND PHARMACOLOGY OF COLUBRID SNAKE VENOMS Stephen P. Mackessya )

These rear-fanged snakes deliver venom under low presdsure as compared to the vipers and studies of enom have been hindered by the difficulty of collecting venom from live snakes without introducing contamination.Better methods involving general anesthesia have been adopted.

Viperidae (true vipers)

In the vipers, which furnish examples of the most highly developed venom delivery apparatus, although inferior to some in its toxic effects, the venom gland is very large and in intimate relation with the masseter or temporal muscle, consisting of two bands, the superior arising from behind the eye, the inferior extending from the gland to the mandible. A groove or duct can be located traveling from the modified salivary glands where venom is produced down the length of the fang and out to the tip. In some species, notably the vipers and cobras, this groove is completely closed over. In other species, such as the adders and mambas, this groove is not covered, or only covered partially. From the anterior extremity of the gland the duct passes below the eye and above the maxillary bone, where it makes a bend, to the basal orifice of the venom fang, which is ensheathed in a thick fold of mucous membrane, the vagina dentis. By means of the movable maxillary bone hinged to the prefrontal, and connected with the tranverse bone which is pushed forward by muscles set in action by the opening of the mouth, the tubular fang is erected and the venom discharged through the distal orifice in which it terminates. When the snake bites, the jaws close up, causing the gland to be powerfully wrung, and the venom pressed out into the duct.

Effects of Venom

Hemorrhage

Enzymes that break down proteins are called proteases, and some special proteases in snake venom can break down clots and interfere with the formation of clots in prey animals. These metalloproteases include

Paralysis

Some proteins secreted in snake venoms are toxins that affect nerves (neurotoxins) and the contractibilty of muscle. Most neurotoxins in snake venoms are too large to cross the blood-brain barrier. This means that the venoms usually exert their effects on the peripheral nervous system rather than directly on the brain and spinal cord. Many of these neurotoxins cause paralysis by blocking the neuromuscular junction. In fact, biologists first learned some of the details of how the neuromuscular junction normally functions by using purified snake venoms in physiology experiments.

The Neuromuscular Junction

The neuromuscular junction is the microscopic connection between a motor nerve fiber and a muscle fiber. It is a type of synapse. A chemical neurotransmitter, acetylcholine, is released by the axons of the motor nerve, and diffuses across the synapse of the neuromuscular junction, to be taken up by the muscle fiber on the other side of this tiny space between the nerve ending and the muscle cell membrane. The acetylcholine molecule stimulates receptors on the muscle cell which then depolarizes and moves (contracts). This effect of acetylcholine is quickly stopped by acetylcholinesterase, an enzyme that specifically breaks down the acetylcholine molecule. Once acetylcholinesterase removes aceytlcholine from the receptor switch on the muscle cell membrane, the receptor is again clear and the process can repeat. Should there be a problem with the activity of acetylcholinesterase, the neurotransmitter acetylcholine will stay on the muscle cell receptor and keep the muscle cell in contraction, in a form of tetany.

Neurotoxins in snake venom can block transmission of acetylcholine from nerve to muscle at the side of the nerve ending (pre-synaptic literally, before the synapse) or affect the activity of the muscle fiber past the synapse (post-synaptic literally after the synapse). Most commonly, the postsynaptic method of producing paralysis is an anti-cholinesterase toxin in venom that prevents the acetylcholinesterase enzyme from clearing the muscle receptor of the acetylcholine transmitter molecule. Most snake venoms contain toxins that cause paralysis by both methods: pre and postsynaptic interference. (ref: Lewis RL. Gutmann L. Snake venoms and the neuromuscular junction. [Review] [26 refs] [Journal Article. Review] Seminars in Neurology. 24(2):175-9, 2004 Jun. UI: 15257514). Presynaptic neurotoxins are commonly called [beta]-neurotoxins and have been isolated from venoms of snakes of families Elapidae, Viperidae, Crotalidae, and Hydrophiidae. [beta]-Bungarotoxin was the first presynaptically active toxin to be isolated from Bungarus multicinctus (Banded Krait) of the Elapidae family.

Blood clotting

Many components in snake venom act to disrupt normal blood flow and normal blood clotting. When many tiny blood clots form in the bloodstream there is a pathological condition known as disseminated intravascular coagulation (DIC). Some enzymes in snake venom set off DIC in the bloodstream of their envenomated prey by XXXX.

Other components of many snake venoms increase bleeding in prey animals by breaking down established clots. An additional mechanism that increases bleeding are components that inhibit the aggregation of platelets, those small odd-shaped blood cells that collect at the site of a tear in a blood vessel and form a plug to close it.

Immunity

Antivenom

Antivenoms are antibodies made by injecting partially denatured proteins from snake venoms into large host animals, such as horses or sheep, in low enough doses so that the animal is not harmed, but produces serum antibodies to the active components of the venom. Early forms of antivenoms were problematic because whole horse serum eas used, and many people suffered reactions to the plasma of horses. As refinements have been made in the purification of the antibody fractions of the serum, allergic and other reactions have been reduced.

Since antivenoms are specific antidotes that neutralize the particular active toxins of venoms, the type of antivenom must be properly matched to the snake responsible for the bite. Antivenoms have revolutionized the treatment for the more deadly snake enovamtions. For example, a recent report of the first manufacture of a horse antivenom for the Bungarus canida snake in Vietnam changed the course of a group of patients from an 80% mortality to 100% recovery. (Trinh, Kiem Xuan; Trinh, Long Xuan; et al. The Production Of bungarus Candidus Antivenom From Horses Immunized With Venom & it's Application For The Treatment Of Snake Bite Patients In Vietnam: 75. Therapeutic Drug Monitoring. 27(2):230, April 2005.)

Regional considerations

Even in those areas where laws against the keeping venomous snakes in captivity exist, enforcement is not strict enough to prevent this practice entirely. Additionally, although rare in occurance, snakes can be introduced into distant locations through importation of goods. Therefore, snake bite by a a venomous snake that is not native to a particular geographic region is possible. However, statistically, the number and type of snake bites in the general population occurs in geographic distribution that reflects the native habitat of these snakes, and, sometimes, occupations and recreational practices by residents and travellers that are higher risk for snake bite. Most envenomations from snakes occur in tropical countries.